This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

AIRE trial

Authoring team

2006 patients with acute myocardial infarction, complicated at any time by left ventricular failure, were randomised to:

  • ramipril, an ACE-inhibitor, 5 mg twice daily
  • placebo

Randomisation took place 3-10 days post-MI (mean 5 days).

Treatment with ramipril resulted in:

  • an absolute reduction in mortality of 6%
  • an odds reduction for death of 26%
  • the prevention of 45 premature deaths per 1000 patient years

Reference:

  • Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. (1993). Lancet, 342, 821-8.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.